SCHEMBL6027127

SCHEMBL6027127

Clc1ccc(COc2cccc3cccnc23)c(Cl)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.55
▸ LMNA P02545 5/20 0.55
▸ MAPT P10636 5/20 0.55
▸ HPGD P15428 3/20 0.55
▸ SMN1; SMN2 Q16637 3/20 0.55
▸ HTT P42858 2/20 0.55
▸ ALDH1A1 P00352 2/20 0.55
▸ NPSR1 Q6W5P4 2/20 0.55
▸ RAB9A P51151 4/20 0.55
▸ NPC1 O15118 3/20 0.55
▸ POLB P06746 2/20 0.53
▸ GAA P10253 2/20 0.53
▸ MEN1 O00255 3/20 0.52
▸ KMT2A Q03164 3/20 0.52
▸ FABP3 P05413 1/20 0.51
▸ FABP4 P15090 1/20 0.51
▸ FABP5 Q01469 1/20 0.51
▸ CYP1A2 P05177 3/20 0.49
▸ CYP2C9 P11712 3/20 0.49
▸ L3MBTL1 Q9Y468 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6026510 0.85 MEN1 (0.58) KDM4ELMNAMAPTHPGDSMN1; SMN2
SCHEMBL6021515 0.84 RAB9A (0.67) KDM4ELMNAMAPTHPGDSMN1; SMN2
SCHEMBL6021785 0.80 NPC1 (0.62) KDM4ELMNAMAPTHPGDSMN1; SMN2
SCHEMBL488869 0.80 NPC1 (0.59) KDM4ELMNAMAPTSMN1; SMN2HTT
SCHEMBL6027050 0.80 NPC1 (0.75) KDM4ELMNAMAPTHPGDSMN1; SMN2
SCHEMBL6026273 0.79 KDM4E (0.56) KDM4ELMNAMAPTHPGDSMN1; SMN2
SCHEMBL6026902 0.78 NPC1 (0.64) KDM4ELMNAMAPTHPGDSMN1; SMN2
SCHEMBL22504147 0.78 LMNA (0.61) KDM4ELMNAMAPTHPGDSMN1; SMN2
SCHEMBL645561 0.78 RAB9A (0.66) KDM4ELMNAMAPTHPGDSMN1; SMN2
SCHEMBL6026966 0.78 RAB9A (0.59) KDM4ELMNAMAPTHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1075483-B1 HYGROMYCIN A DERIVATIVES PFIZER PROD INC (US) 2003-12-03 — — EP claimed
EP-1077984-B1 2\"-DEOXY HYGROMYCIN DERIVATIVES PFIZER PROD INC (US) 2003-06-18 — — EP claimed
US-6342497-B1 2″-deoxy hygromycin derivatives PFIZER INC 2002-01-29 — — US claimed
US-6313100-B1 ANTIBACTERIAL, ANTIPROTOZOA AGENTS PFIZER INC 2001-11-06 — — US claimed
EP-1369490-B1 Method of preparing a composition containing hygromycin A and epi-hygromycin PFIZER PROD INC (US) 2006-02-08 — — EP disclosed
WO-2004108114-A2 ANTI-FUNGAL COMPOSITION AND A PROCESS FOR ITS MANUFACTURE PATEL DINESH SHANTILAL (IN) 2004-12-16 — — WO disclosed
WO-2004069145-A2 ANTICANCER COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DR. REDDY'S LABORATORIES LTD. (IN) 2004-08-19 — — WO disclosed
EP-1369490-A1 Method of preparing a composition containing hygromycin A and epi-hygromycin Pfizer Products Inc. (US) 2003-12-10 — — EP disclosed
EP-1075483-B1 HYGROMYCIN A DERIVATIVES PFIZER PROD INC (US) 2003-12-03 — — EP disclosed
EP-1077984-B1 2\"-DEOXY HYGROMYCIN DERIVATIVES PFIZER PROD INC (US) 2003-06-18 — — EP disclosed
US-6342497-B1 2″-deoxy hygromycin derivatives PFIZER INC 2002-01-29 — — US disclosed
US-6313100-B1 ANTIBACTERIAL, ANTIPROTOZOA AGENTS PFIZER INC 2001-11-06 — — US disclosed
Send feedback